Drawing for MICROLOCK

USPTO serial 99388011

MICROLOCK

Reviewed by CopyMark Law Group

Reg. 8351344Status 700Registered
Filing date
Status date
Registration date
Jul 21, 2026
Examiner
FARRAG, SHERIF G
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MICROLOCK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Harris A. Wolin

Harris A. Wolin Myers Wolin, LLC100 South Jefferson Road, Suite 202Whippany, NJ 07981United States

Goods and services

ClassDescriptionStatusFirst use
003Skin care preparations for patch-shaped functional cosmetics including microneedles; Beauty microneedle patch; Patches containing sun screen and sun block for use on the skin; Cosmetic patches containing sunscreen and sun block for use on the skin; Gel eye patches for cosmetic purposes; Non-medicated skin care preparations in the form of dissolvable microneedle patches, namely, gels, serums, creams, toners, and skin-rejuvenating essences; Patches containing non-medicated cosmetic formulations delivered by dissolvable microneedles; Patches containing non-medicated UV-blocking agents; Gel eye patches containing non-medicated skin care preparations; Beauty microneedle patches containing non-medicated skin care preparations; Cosmetic microneedle patches containing sun protection preparations; Gel-based microneedle eye patches for cosmetic purposesACTIVE—
005Vitamin supplement patches; Adhesive skin patches for use in post-operative wound care; Skin patches for the transdermal delivery of pharmaceuticals; Drug delivery agents in the form of compounds, powders, and tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; Delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; Microneedle patch for medical purposes; Adhesive bandages for medical purposes; Adhesive skin patches for medical use; Transdermal patches for medical treatment of the skin; Transdermal microneedle patches for accelerating postoperative wound healing and scar reduction; Microneedle patches featuring salicylic acid and benzoyl peroxide for acne treatment; Microneedle patches featuring lidocaine for local pain relief; Microneedle patches featuring antihistamines for skin allergy management; Drug delivery agents in the form of dissolvable microneedle films and coatings that enhance penetration, sustained release of pharmaceutical preparations; Transdermal microneedle patches for delivering therapeutic active ingredients for addressing problems related to metabolic disorders, smoking cessation and neuromodulation, vaccination and immunotherapy, dermatology, pain and neurology, hormonal and systemic therapy, oncology, obesity and regenerative medicine and advanced biologics; Adhesive microneedle bandages containing analgesics or antimicrobial agents for wound healing and pain relief; Medical adhesive microneedle patches for delivering corticosteroids and antibiotics for dermatological conditions such as eczema and dermatitis; Transdermal microneedle patches for delivering prescription drugs for chronic pain, hormonal regulation, and metabolic disorder managementACTIVE—
010Medical apparatus and instruments using microneedles for drug delivery; Cooling patches for medical purposes; Needles for medical purposes; Heating patches for medical treatment; Acupuncture needles; Medical apparatus and instruments incorporating microneedle arrays for drug delivery; Microneedle cooling patches for medical purposes; Microneedles and hypodermic needles for medical use; Chemically activated microneedle heating patches; Acupuncture microneedlesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 21, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 21, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 2, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 2, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 5, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 5, 2026XAECEXAMINER'S AMENDMENT ENTERED—
May 5, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 5, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
May 5, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
May 2, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 1, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 1, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 17, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2026DOCKASSIGNED TO EXAMINER—
Feb 3, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 11, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 11, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance